Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 20,019	$ 6,532	$ 39,811	$ 23,804
General and administrative	4,731	3,355	13,021	11,000
Total operating expenses	24,750	9,887	52,832	34,804
Loss from operations	(24,750)	(9,887)	(52,832)	(34,804)
Other income (expense), net:
Interest expense	(388)	(2,403)	(2,048)	(5,235)
Interest and other income	2,037	499	5,534	2,052
Loss from changes in fair value of warrants and derivative liabilities	(306)	(2,834)	(384)	(4,909)
Loss on extinguishment of debt			(250)
Total other income (expense), net	1,343	(4,738)	2,852	(8,092)
Net loss	$ (23,407)	$ (14,625)	$ (49,980)	$ (42,896)
Net loss per share attributable to common stockholders, Basic	$ (6.7)	$ (8.74)	$ (21.76)	$ (25.64)
Net loss per share attributable to common stockholders, Diluted	$ (6.7)	$ (8.74)	$ (21.76)	$ (25.64)
Weighted-average common shares outstanding, basic	3,494,580	1,672,726	2,297,397	1,672,701
Weighted-average common shares outstanding, dilutive	3,494,580	1,672,726	2,297,397	1,672,701
Comprehensive loss:
Net Income (Loss)	$ (23,407)	$ (14,625)	$ (49,980)	$ (42,896)
Foreign currency translation adjustment	58	35	55	67
Total comprehensive loss	$ (23,349)	$ (14,590)	$ (49,925)	$ (42,829)